ERBB2 and breast carcinoma: In contrast, ER and PR hormone receptors are negative in HER-2 positive and TNBC breast cancer, the expression of PBK/TOPK is higher, and the expression level of PBK/TOPK is negatively correlated with the positive expression of ER and PR.